1. Home
  2. CARM vs ADN Comparison

CARM vs ADN Comparison

Compare CARM & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CARM
  • ADN
  • Stock Information
  • Founded
  • CARM 2016
  • ADN 2006
  • Country
  • CARM United States
  • ADN United States
  • Employees
  • CARM N/A
  • ADN N/A
  • Industry
  • CARM Biotechnology: Pharmaceutical Preparations
  • ADN Power Generation
  • Sector
  • CARM Health Care
  • ADN Utilities
  • Exchange
  • CARM Nasdaq
  • ADN Nasdaq
  • Market Cap
  • CARM 7.7M
  • ADN 7.5M
  • IPO Year
  • CARM N/A
  • ADN N/A
  • Fundamental
  • Price
  • CARM $0.19
  • ADN $2.45
  • Analyst Decision
  • CARM Hold
  • ADN
  • Analyst Count
  • CARM 5
  • ADN 0
  • Target Price
  • CARM $0.90
  • ADN N/A
  • AVG Volume (30 Days)
  • CARM 956.5K
  • ADN 41.7K
  • Earning Date
  • CARM 05-13-2025
  • ADN 12-27-2024
  • Dividend Yield
  • CARM N/A
  • ADN N/A
  • EPS Growth
  • CARM N/A
  • ADN N/A
  • EPS
  • CARM N/A
  • ADN N/A
  • Revenue
  • CARM $19,964,000.00
  • ADN $8,157,000.00
  • Revenue This Year
  • CARM N/A
  • ADN $2,232.99
  • Revenue Next Year
  • CARM N/A
  • ADN $91.56
  • P/E Ratio
  • CARM N/A
  • ADN N/A
  • Revenue Growth
  • CARM 32.45
  • ADN 274.35
  • 52 Week Low
  • CARM $0.14
  • ADN $1.71
  • 52 Week High
  • CARM $1.90
  • ADN $8.79
  • Technical
  • Relative Strength Index (RSI)
  • CARM 44.76
  • ADN 45.95
  • Support Level
  • CARM $0.14
  • ADN $2.00
  • Resistance Level
  • CARM $0.20
  • ADN $3.07
  • Average True Range (ATR)
  • CARM 0.02
  • ADN 0.27
  • MACD
  • CARM 0.00
  • ADN 0.04
  • Stochastic Oscillator
  • CARM 71.47
  • ADN 42.25

About CARM Carisma Therapeutics Inc.

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.

About ADN Advent Technologies Holdings Inc.

Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.

Share on Social Networks: